Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8+ Cytotoxic T Lymphocytes
Open Access
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (4) , 577-586
- https://doi.org/10.1016/j.ymthe.2003.12.011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15Nature Medicine, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic MalignanciesThe International Journal of Cell Cloning, 2002
- Clinical trials with CMV-specific T cellsCytotherapy, 2002
- Adoptive T-cell therapy for the treatment of solid tumoursExpert Opinion on Biological Therapy, 2002
- Human T Lymphocyte Genetic Modification with Naked DNAMolecular Therapy, 2000
- Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytesNature Medicine, 1996
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992